Validation of the Mexican version of the EORTC QLQ-CR29 in patients with colorectal cancer.
Jazmín Hernández-MarínOscar Galindo-VázquezGerman Calderillo-RuízPatricia Ortega-AndeaneTania EstapéXolyanetzin Montero-PardoErika Ruiz-GarciaMarytere HerreraAbelardo MenesesPublished in: Palliative & supportive care (2024)
The EORTC QLQ-CR29 instrument proved to be a valid and reliable instrument for use in clinical care and research directed at patients with CRC in Mexico. Its use is recommended by multidisciplinary health teams in oncology in Mexico, since it allows knowing the patient's perspective on the impact of CRC on their life, guiding therapeutic decision-making and being a primary outcome measure.